Tag: Mark Durkan

The below Parliamentary question was asked by Mark Durkan on 2016-01-13.

To ask the Secretary of State for Health, if he will ask NHS England to publish a case study of the revised Cancer Drugs Fund (CDF) patient journey and give examples for how people are initiated onto CDF-approved treatments now and how people will be treated under the proposed new CDF scheme.

George Freeman

NHS England and the National Institute for Health and Care Excellence are currently consulting jointly on draft proposals on the future direction of the Cancer Drugs Fund (CDF). The consultation document states that all patients receiving treatment funded through the CDF on 31 March 2016 will continue to receive treatment until the point that they and their consultant agree that it is appropriate to stop.

NHS England has advised that the aim of the future CDF is to help patients receive new treatments with genuine promise, while real world evidence is collected for up to two years on how well they work in practice. This will then help determine whether the treatment should be accepted for routine use in the National Health Service in the future. It is not possible to make comparisons between the current and future CDF until such time as the consultation has concluded and the responses reviewed.

The consultation was published on 19 November 2015 and is open until 11 February 2016. Further information is available at:

www.engage.england.nhs.uk/consultation/cdf-consultation

“

The below Parliamentary question was asked by Mark Durkan on 2016-02-24.

To ask the Secretary of State for Health, what steps his Department is taking to encourage routine use of NHS medicines throughout the NHS.

George Freeman

The Government is committed to ensuring that patients have access to new and effective treatments on terms that represent value to the National Health Service and the taxpayer.

The National Institute for Health and Care Excellence (NICE) is the independent body responsible for providing advice to the NHS on the clinical and cost-effectiveness of health technologies. NHS commissioners are legally required to fund treatments recommended by NICE technology appraisal guidance, ensuring consistent access to clinically and cost effective drugs across England.

The Accelerated Access Review, chaired by Sir Hugh Taylor, will make recommendations to government later this spring on reforms to accelerate access for NHS patients to innovative medicines, medical technologies, diagnostics and digital products.

The below Parliamentary question was asked by Mark Durkan on 2016-05-18.

To ask the Secretary of State for International Development, what plans the Government has to become a founding donor to the Education Cannot Wait fund for education in emergencies.

Mr Nick Hurd

The UK has played a leading role in the development of the Education Cannot Wait fund for education in emergencies and protracted crises, which was launched at the World Humanitarian Summit on 23rd May.　 The UK has committed to provide £30million in support over two years to the new fund as a founding donor, which was announced by the International Development Secretary at the fund’s launch.

The below Parliamentary question was asked by Mark Durkan on 2016-10-07.

To ask the Secretary of State for Foreign and Commonwealth Affairs, how many people with dual Palestinian and British citizenship have been (a) refused entry to, (b) detained by and (c) deported by Israel in the last 12 months.

Mr Tobias Ellwood

Palestinians are not allowed to enter Israel through Ben-Gurion Airport. Dual British/Palestinian nationals enter on their Palestinian documents through Allenby Bridge. We are not aware of any Dual nationals who have been refused entry.

The below Parliamentary question was asked by Mark Durkan on 2015-11-05.

To ask the Secretary of State for Foreign and Commonwealth Affairs, what assessment he has made of the time taken by the Cayman Islands government to respond to its consultation on a public register of beneficial ownership.

James Duddridge

I refer the Honourable Gentleman to the answer given by my Rt Hon Friend, the Member for South West Hertfordshire (David Gauke MP), the Financial Secretary to the Treasury, to questions 10437, 10438 and 10448, which sets out the criteria we expect the Overseas Territories to meet in relation to their central register of company beneficial ownership, or similarly effective system.

We are continuing our dialogue with the Anguilla authorities on this and have offered any technical support that might be required as they develop their proposals.

The below Parliamentary question was asked by Mark Durkan on 2016-01-13.

To ask the Secretary of State for Health, what discussions the his Department, NHS England and NICE have had on the effect of proposed Cancer Drugs Fund (CDF) changes on patients prescribed current CDF treatments who will not receive interim funding under that proposed new scheme.

George Freeman

NHS England and the National Institute for Health and Care Excellence are currently consulting jointly on draft proposals on the future direction of the Cancer Drugs Fund (CDF). The consultation document states that all patients receiving treatment funded through the CDF on 31 March 2016 will continue to receive treatment until the point that they and their consultant agree that it is appropriate to stop.

NHS England has advised that the aim of the future CDF is to help patients receive new treatments with genuine promise, while real world evidence is collected for up to two years on how well they work in practice. This will then help determine whether the treatment should be accepted for routine use in the National Health Service in the future. It is not possible to make comparisons between the current and future CDF until such time as the consultation has concluded and the responses reviewed.

The consultation was published on 19 November 2015 and is open until 11 February 2016. Further information is available at:

www.engage.england.nhs.uk/consultation/cdf-consultation

“

The below Parliamentary question was asked by Mark Durkan on 2016-02-24.

To ask the Secretary of State for Health, if his Department, NHS England and NICE will publish work undertaken to analyse variation between areas in treatment for patients during the transition from the current Cancer Drugs Fund (CDF) to proposed a new CDF scheme.

George Freeman

NHS England has advised that it plans to publish analyses of variation in use of Cancer Drug Fund (CDF) drug indications according to geographical areas in the spring of 2016 and then routinely in the future for the new CDF.

The below Parliamentary question was asked by Mark Durkan on 2016-05-19.

To ask the Secretary of State for Foreign and Commonwealth Affairs, if his Department will make representations to the government of Sudan on the arrests and daily reporting conditions imposed on at least six clergymen and two lay members from three church denominations in Khartoum since December 2015.

James Duddridge

Freedom of religion or belief in Sudan continues to be an area of concern for the UK. We have consistently called on the Government of Sudan to ensure all legislation is in line with the commitment to their citizens in the Interim Constitution of 2005; within which religious freedom is enshrined. Our Embassy in Khartoum raised the detention and requirement to report on a daily basis to the National Intelligence and Security Service, with the Ministry of Foreign Affairs on 10 May.

The below Parliamentary question was asked by Mark Durkan on 2016-10-07.

To ask the Secretary of State for Foreign and Commonwealth Affairs, how many UK citizens have been deported by Israel after initially being granted entry to the state in the last 12 months.

Mr Tobias Ellwood

​We are not aware of any British nationals that have been deported after being allowed entry, with the exception of people who have overstayed their visa.

The below Parliamentary question was asked by Mark Durkan on 2015-11-05.

To ask the Secretary of State for Foreign and Commonwealth Affairs, if he will ensure that any agreement on a central registry of beneficial ownership in Anguilla will include access for the public with legitimate reason.

Mr Hugo Swire

I refer the Honourable Gentleman to the answer given by my Rt Hon Friend, the Member for South West Hertfordshire (David Gauke MP), the Financial Secretary to the Treasury, to questions 10437, 10438 and 10448, which sets out the criteria we expect the Overseas Territories to meet in relation to their central register of company beneficial ownership, or similarly effective system.

We are continuing our dialogue with the Anguilla authorities on this and have offered any technical support that might be required as they develop their proposals.